The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...

GP Dr Roger Henderson provides an overview of the chronic complications of diabetes and the key preventive measures undertaken in primary careDiabetes can lead to a range of chronic complications if ...

The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a serious complication.

Participants with metabolic syndrome who received 1,700 mg metformin daily with or without a Mediterranean diet intervention had reduced incidence of diabetes compared with placebo, according to ...

A lack of essential micronutrients, such as vitamin D and magnesium, as well as a few others, may be behind 'hidden hunger' ...

Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been making waves in the healthcare sector with its groundbreaking treatments for ...

The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...

If that person loses 20 kilograms (44 pounds) in one year while taking a GLP-1R agonist — which is not unreasonable while ...

Metabolic dysfunction-associated steatotic liver disease, or MASLD, is an umbrella term describing conditions related to a ...

The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...

Vitamin D, magnesium, and B12 deficiencies were common among people with type 2 diabetes according to new research.